| Patents for C07J 7 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of two carbon atoms (2,018) |
|---|
| 02/23/2010 | CA2319916C Use of dhea, its precursors or its metabolic derivatives as a depigmentation agent |
| 02/11/2010 | WO2010015528A1 New no-releasing steroids for the treatment of retina and macula lutea diseases |
| 02/11/2010 | US20100034781 Oxysterol Compounds and the Hedgehog Pathway |
| 02/11/2010 | CA2731520A1 New no-releasing steroids for the treatment of retina and macula lutea diseases |
| 02/09/2010 | CA2403756C Structural modification of 19-norprogesterone i: 17-.alpha.-substituted, 11-.beta.-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents |
| 01/27/2010 | CN101633682A Refining technique of intermediate acetate arachidonic substance of triamcinolone acetonide series products |
| 01/21/2010 | US20100016597 Method for producing pulverized organic compound particle |
| 01/13/2010 | EP2142194A1 Mineralocorticoid receptor antagonists |
| 12/30/2009 | EP1470151B1 Process for the preparation of 7-alpha-methylsteroids |
| 12/24/2009 | US20090318720 Process for selectively synthesising 3 alpha-hydroxychlormadinone acetate |
| 12/16/2009 | CN101601674A Pregnane steroids for use in the treatment of cns disorders |
| 11/26/2009 | WO2009141110A1 Method for the selective synthesis of 3-alpha-hydroxy-chlormadinone acetate |
| 11/26/2009 | US20090291932 Pharmaceutical solid state forms |
| 11/12/2009 | WO2009136629A1 Prophylactic/therapeutic agent for lifestyle-related diseases |
| 11/12/2009 | US20090281071 Therapeutic agent for hypertension |
| 10/29/2009 | US20090270642 Preparation of bile acids and intermediates thereof |
| 10/28/2009 | CN101565442A Novel estrogenic compound, preparation method and application thereof |
| 10/15/2009 | US20090258849 Nitrooxy derivatives of glucocorticoids |
| 10/15/2009 | US20090258847 Cholanic Acid Amides |
| 10/06/2009 | US7598234 Steroid derived antibiotics |
| 09/29/2009 | CA2394079C Weight promoting composition, method and product |
| 09/23/2009 | CN101538302A 16alpha-methyl-3-hydroxyl-19-norpregnane-1, 3, 5-triene-20-ketone and preparation method thereof |
| 09/23/2009 | CN101537344A Monolithic column, preparation method and application thereof |
| 09/09/2009 | EP2097437A1 The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of cns disorders |
| 09/08/2009 | CA2253673C 21-substituted progesterone derivatives as new antiprogestational agents |
| 09/02/2009 | CN101518537A Preventives/remedies for inflammatory airway diseases |
| 09/01/2009 | CA2438799C Preventative of therapeutic agent for inflammatory respiratory tract disease |
| 08/20/2009 | US20090205784 Article support structure and article attachment kit |
| 08/19/2009 | EP2088865A2 Guggulphospholipid methods and compositions |
| 08/19/2009 | CN101508640A Method for recycling dilute acetic acid with azeotropic abstraction distillation |
| 08/06/2009 | WO2009069032A3 Novel glucocorticoid receptor agonists |
| 07/22/2009 | CN100516083C Glycosylated steroid derivatives with anti-migratory activity |
| 07/01/2009 | CN100506776C NK1 antagonists |
| 06/04/2009 | WO2009069032A2 Novel glucocorticoid receptor agonists |
| 06/04/2009 | WO2008148473A3 Method for the production of 17 alpha-acetoxy-6-methylenepregn-4-ene-3,20-dione, medroxyprogesterone acetate, and megestrol acetate |
| 05/28/2009 | US20090137542 Alpha-glucosidase inhibitors from fungal hydroxylation of tibolone and hydroxytibolones |
| 05/28/2009 | US20090136434 Tyrosinase enzyme inhibitors from fungal hydroxylation of tibolone |
| 05/22/2009 | WO2008110941A3 New process of synthesis of a squalamine and/or trodusquemine precursor |
| 05/14/2009 | WO2009039103A3 Fragrance compositions and other compositions which contain naturally occurring substances found in corals |
| 05/12/2009 | CA2303448C Specific steady-state r-type ca2+ channel blockers and use thereof |
| 05/07/2009 | US20090118248 3-Alpha-hydroxy 21-n-heteroaryl-pregnane derivatives for modulation of brain excitability and a process for the production thereof |
| 04/28/2009 | CA2344686C High purity composition comprising (7.alpha.,17.alpha.)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one |
| 04/22/2009 | CN101412742A Nitric acid ester medicament for inhibiting angiogenesis |
| 04/08/2009 | EP1976997B1 Process for the preparation of 11beta-hydr0xy-9beta,10alpha-steroids employing amycolatopsis mediterranei cells |
| 04/08/2009 | CN101402664A Method for producing high purity diene alcohol ketone acetic ester |
| 04/07/2009 | US7514420 Steroids having 1,8-unsaturation and formulations comprising same |
| 04/01/2009 | CN101397325A Preparation of fluorometholone and derivatives thereof |
| 04/01/2009 | CN101397324A Preparation of metacortandralone and derivatives thereof |
| 04/01/2009 | CN101397320A Method for preparing dexamethasone and series products thereof |
| 04/01/2009 | CN101397319A Method for preparing betamethasone and series products thereof |
| 04/01/2009 | CN101397317A Novel nitric acid esters steroidal compounds |
| 03/26/2009 | CA2698903A1 Fragrance compositions and other compositions which contain naturally occurring substances found in corals |
| 03/24/2009 | US7507767 Sulfonamide-containing benzene derivatives which exhibit anti-inflammatory and immunodulatory activity |
| 03/18/2009 | CN100469786C Method for synthesizing 16-dehydropregndiketonic alcohol acetic ester and its analogs |
| 03/18/2009 | CN100469764C Vitamin D derivatives |
| 03/12/2009 | US20090069584 Levonorgestrel Crystallization |
| 03/11/2009 | EP2033965A2 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 03/10/2009 | US7501135 Gastric acid secretion |
| 03/04/2009 | CN101379156A Article support structure and article attachment kit |
| 02/04/2009 | CN101360832A Process for the preparation of 11beta-hydroxy-9beta,10alpha-steroids employing amycolatopsis mediterranei cells |
| 01/20/2009 | CA2423020C Use of antiprogestins for the induction of apoptosis in a cell |
| 01/14/2009 | EP1602404B1 Medicament in fine particle form, method and device for preparation thereof, and agent for parenteral injection and method for production thereof |
| 01/08/2009 | US20090012321 Process for preparing 17alpha-acetoxy-6-methylenepregn-4-ene-3,20-dione, medroxyprogesterone acetate and megestrol acetate |
| 01/06/2009 | CA2423017C Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases |
| 12/24/2008 | WO2008157652A1 Deuterium-enriched fluticasone propionate |
| 12/16/2008 | CA2395129C Process for producing nanometer particles by fluid bed spray-drying |
| 12/16/2008 | CA2327714C Preparation of 4,4-dimethyl-5.alpha.-cholesta-8,14,24-triene-3.beta.-o1 and novel intermediate compounds |
| 12/11/2008 | DE102007026636A1 Verfahren zur Herstellung von 17α-Acetoxy-6-methylenpregn-4-en-3,20-dion, Medroxyprogesteronacetat und Megestrolacetat Process for preparing 17α-acetoxy-6-methylenpregn-4-ene-3,20-dione, medroxyprogesterone acetate and megestrol acetate |
| 12/10/2008 | CN101318982A Process for synthesizing 3-acetoxy-9 beta, 10 alpha-pregna-5, 7-diene-20-ketone |
| 11/26/2008 | EP1473300B1 Pharmaceutical composition for the treatment of psoriasis and other skin diseases |
| 11/12/2008 | CN100432093C High-purity composition comprising (7a,17a)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one and a process for purifying (7a,17a)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one |
| 11/06/2008 | WO2008067086A3 Compositions and methods for suppressing endometrial proliferation |
| 10/29/2008 | CN100429222C Synthesis process of a pregnane compound |
| 10/29/2008 | CN100429221C Synthesis method of cortin |
| 10/15/2008 | EP1979429A1 Article support structure and article attachment kit |
| 10/15/2008 | EP1979307A1 Neutral labeling reactants and conjugates derived thereof |
| 10/09/2008 | WO2008119918A1 Mineralocorticoid receptor antagonists |
| 10/09/2008 | US20080249075 C11 Modified Retrosteroids as Progesterone Receptor Modulator Compounds |
| 10/09/2008 | CA2680533A1 Mineralocorticoid receptor antagonists |
| 10/08/2008 | EP1976997A1 Process for the preparation of 11beta-hydr0xy-9beta, 10alpha -steroids employing amycolatopsis mediterranei cells |
| 08/27/2008 | CN101250211A Pregna-16-ene-20S-acetate compound and method for synthesizing same |
| 08/26/2008 | US7416744 Extracts, compounds and pharmaceutical compositions having anti-diabetic activity and their use |
| 08/26/2008 | CA2394731C Process for preparing 17alpha-acetoxy-11beta-[4-n,n-(dimethylamino)phenyl]-21-methoxy-19-norpregna-4,9-diene-3,20-dione, intermediates useful in the process, and processes for preparing such intermediates |
| 08/20/2008 | EP1380302B1 Remedies for retina and choroid diseases containing steroids as the active ingredient |
| 08/13/2008 | CN101239090A Pharmaceutical compositions having appetite suppressant activity |
| 08/13/2008 | CN101239089A Pharmaceutical compositions having appetite suppressant activity |
| 07/16/2008 | CN100402546C Steroid compounds with anti-tumor activity |
| 07/03/2008 | US20080159971 Use of dhea or precursors or metabolic derivatives thereof as a depigmenting agent |
| 07/02/2008 | CN100398553C Chemical synthesis of free megestrol |
| 06/11/2008 | EP1420769B1 Lipid profile modulation with steroids and ppar alpha agonists |
| 06/10/2008 | CA2259981C 6,7-oxygenated steroids and uses related thereto |
| 06/05/2008 | CA2673128A1 Compositions and methods for suppressing endometrial proliferation |
| 06/04/2008 | EP1927359A2 2-Methoxyestradiol for the treatment of inflammatory disorders |
| 05/29/2008 | WO2008063128A1 The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of cns disorders |
| 05/29/2008 | US20080125407 Method for preparation of fluticasone propionate |
| 05/29/2008 | CA2833976A1 The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of cns disorders |
| 05/29/2008 | CA2664126A1 The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of cns disorders |
| 05/28/2008 | EP1344526B1 Preventives/remedies for inflammatory airway diseases |
| 05/27/2008 | US7378406 11 beta -(4-acetylphenyl)-17 beta-hydroxy-17-alpha-(1,1,2,2,2-pentafluoroethyl)-estra-4,9-dien-3-one or a derivative, especially for prophylaxis and treatmenet of breast cancer |
| 05/22/2008 | US20080119416 pregnane or androstane steroids for use in methods of prevention, alleviation or treatment of CNS disorders, nervous system disorders |